OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
$50 Million
Sole Agent
At-the-Market Facility
March 2025
$350 Million
Joint Bookrunner
Rule 144A Convertible Senior Notes Offering
March 2025
$75 Million
Joint Bookrunner
Follow-On
February 2025
$235 Million
Joint Lead Bookrunner
Initial Public Offering
January 2025
Featured Insights
Articles
February 2026
PCSK9 Inhibitors: Cost-Effective for Primary Prevention?
Podcasts
February 2026
Specialty Drug Coverage Predictions with James Chambers, PhD, MPharm, Professor of Medicine, CEVR, Tufts Medical Center
Featured Research
February 2026
